Free Tool · Pricing, Profitability & Portfolio

Product Portfolio X-Ray

Every SKU earns its place — or explains why it stays. X-ray the portfolio.

Every SKU earns its place or explains why it stays. Enter sales, contribution, growth and stock turns; the X-Ray groups the portfolio into heroes, fixes, maintainers and retire-review candidates — with strategic SKUs protected from the axe.

For: Category / Business Head·Free — no sign-up for results·Related service: Product & Portfolio Strategy
SKUNet sales ₹Contrib. %Growth %Stock turnsStrategic?
Tick "Strategic?" for channel-entry or bundle SKUs — they get investigated, never auto-killed. Low-selling is not automatically low-value.
Portfolio read (4 SKUs)
Portfolio average contribution: 30.46% · Total net sales: ₹72.4 L
Heroes (1)
SKU-A100 · 69.06%
Fix the economics (1)
SKU-B200 · 27.62%
Investigate (strategic role) (1)
SKU-D400 · 1.24%
Retire-review (1)
SKU-C300 · 2.07%
Your numbers stay in your browser until you choose to download or share.

How it works

SKUs are grouped by revenue share (meaningful vs tail) against portfolio-average contribution: big-and-healthy = hero; big-but-thin = fix; small-but-healthy = maintain; small-and-thin = retire-review.

Strategic-role SKUs (channel entry, bundle anchors) go to 'investigate' with their rationale required — the tool never auto-kills.

Stock turns expose inventory burden: a tail SKU with 1 turn ties up cash even if its margin looks acceptable.

Worked example

A 4-SKU portfolio shows one hero (35% contribution), one fix candidate with scale but weak margin, and a tail SKU burning shelf space — while the 'strategic' entry SKU stays, with its rationale documented.

Illustrative figures, not a client outcome.

Questions, answered

How often should we X-ray the portfolio?

Twice a year for stable categories, quarterly for fast ones. Portfolio creep is silent — you notice it in warehouse cost before in sales.

What if a tail SKU is growing fast?

Growth changes the grouping — a fast-growing tail SKU with decent margin is tomorrow's hero. The growth column exists exactly for that.

Version 1.0 · Reviewed 2026-10 · Methodology is fixed and version-controlled; results depend on your inputs.

Portfolio X-rayed. Now rationalise without losing the strategic bets.

BLEZZINGS runs this analysis inside a focused engagement — with your data, your market and a plan to act on it.